| Title | Quantitative volumetry in patients with carotid disease--effects of acetazolamide. | | Author(s) | Eicke BM, Bähr RR, Buss E, Doberenz C, Paulus W | | Institution | Department of Clinical Neurophysiology, University of Göttingen, Germany. eicke@neurologie.klinik.uni-mainz.de | | Source | J Neuroimaging 2001 Jan; 11(1):13-7. | | MeSH | Acetazolamide
Aged
Blood Flow Velocity
Blood Volume
Carbonic Anhydrase Inhibitors
Carotid Artery, Common
Carotid Artery, Internal
Carotid Stenosis
Cerebrovascular Circulation
Collateral Circulation
Humans
Middle Aged
Middle Cerebral Artery
Ophthalmic Artery
Ultrasonography, Doppler, Transcranial
Vasodilator Agents
| | Abstract | The intracranial effects of acetazolamide on flow velocities can be monitored noninvasively by transcranial Doppler (TCD) sonography. Extracranial volume flow changes can now reliably be measured with color duplex M-mode systems. The authors tested the volumetric effects of acetazolamide in patients with high-grade unilateral carotid disease to quantify the amount of flow changes. Patients in group 1 had a high-grade > 70% internal carotid artery (ICA) stenosis, without collateral flow through the ophthalmic artery (OA). Patients with occluded ICA were included in group 2 (patent OA collateralization) or group 3 (no OA collateralization) (n = 6 per group). In group 1, common carotid artery (CCA) volume flow in the stenotic (normal contralateral) side increased from 271 (388) ml/min by 52 (54%) with 1 g aceta-zolamide intravenously. Simultaneously, middle cerebral artery (MCA) flow velocities increased from 54 (56) cm/s by 47 (53%). In group 2, extracranial volume flow increased from 166 (444) ml/min by 19 (52)%. MCA flow velocities increased from 43 (65) cm/s by 13 (30)%. In group 3, volume flow increased from 159 (467) ml/min by 2 (46)%. Intracranial flow velocities rose from 49 (54) cm/s by 27 (41)%. Volume flow data showed the expected decline in patients with high-grade ICA stenosis and even more pronounced in patients with occlusion of the vessel. Cerebral reserve capacity was less sufficient in patients with a patent OA, despite an additional supply of 30 ml/min, indicating a hemodynamically critical situation. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 11198521 |
|
